Navigation Links
Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancer
Date:8/29/2013

AUG. 29, 2013, Cleveland:

The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.

Prostate cancer requires a constant supply of androgens in order to sustain itself. The current standard of care for patients with metastatic prostate cancer is medical castration, the ability to interfere with the body's production of testosterone (androgens) using medications that disrupt the process. Oftentimes, metastatic prostate cancer flourishes despite the lack of testosterone in the bloodstream, creating CRPC. These tumors are able to exist without the body's supply of testosterone by creating androgens within the tumor cell; however, increased androgen synthesis has not yet been attributable to any known mutations. The Cleveland Clinic discovery shows that the 3βHSD1 mutation makes this enzyme hyperactive to create androgens.

"This discovery gives us the ability to identify molecular subtypes of prostate cancer known to resist treatment. By finding the mutated enzyme, we can now investigate treatments that block it. This kind of strategy is the crux of personalized medicine which is currently used as the standard of care for some forms of lung cancer and melanoma," said Nima Sharifi, M.D., Kendrick Family Chair for Prostate Cancer Research at Cleveland Clinic, who led the research.

The 3βHSD1 mutation can occur within CRPC tumors and it can also come from germline DNA, which is inherited from maternal and paternal sources.

The research found that laboratory models of human prostate cancer fall into two categories of androgen synthesis: those that make androgens slowly and those that do so rapidly. Next, they found that the 3βHSD1 mutation explains the difference between t
'/>"/>

Contact: Stephanie Jansky
JANSKYS@ccf.org
216-363-5869
Cleveland Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CE Lectures on the Dental Treatment of Snoring and Sleep Apnea Include Rochester, Cleveland and Ft. Lauderdale, as Sleep Seminar Destinations
2. Cleveland Indians vs. Detroit Tigers Tickets: Cheap Concert Tickets Slashes Prices on All Indians vs. Tigers Tickets for August 5th - August 8th Series Progressive Field
3. National Transitions of Care Coalition to Host Regional Summit in Cleveland
4. Maroon 5 & Kelly Clarkson Ticket Prices Slashed for Concerts in Long Island, Holmdel, Cincinnati, Pittsburgh, Camden/Philly, Boston/Mansfield, Chicago, Cleveland & Detroi
5. Explorys Proud to Sponsor Cleveland GiveCamp
6. NEONI Participates in Healthcare Career Event at Cleveland Convention Center Grand Opening
7. Cleveland Clinic Laboratories to provide testing and diagnostic services to ACL Laboratories
8. Book of Mormon Tickets: Prices Slashed on Book of Mormon Tickets in New York, Chicago, Cleveland, Buffalo, Washington DC, Minneapolis, Houston and San Antonio
9. Cancer Survivor David Emerson Awarded Volkswagen Cup at Cleveland Marathon
10. Nine Inch Nails Tickets (NIN) Tickets Go On Public Sale for St. Paul, Toronto, Cleveland, Detroit, Boston, Brooklyn, Newark, Washington DC, Las Vegas, Portland on June 14th
11. Justin Timberlake Tickets: Cheap Concert Tickets Announces that Justin Timberlake Tickets Go Onsale 6/3 for Concerts in Omaha, St. Paul, Fargo, Pittsburgh, Cleveland, Indianapolis and St. Louis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 AliCare Medical Management ... management programs and a member of the Amalgamated ... Julie O’Brien as President. O’Brien formerly served as ... In her new role, she will continue with ... of AMM’s call center operations, including clinical services, ...
(Date:3/3/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... that it will participate as an exhibitor at the ... 2015 in St. Louis, MO. , CareerMD Career Fairs ... and fellows in a comfortable, relaxed setting. , Representatives ... available to speak with attendees about its full range ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Calvary ... at their Brooklyn Satellite in Lutheran Medical Center, ... quarterly award must demonstrate excellence through clinical expertise ... also expected to go above and beyond to ... presence with patients and their families. Award recipients ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Cutler Integrative ... get to the root, gives cutting-edge tips to bring ... way to renew the body by first cleaning house. ... Naturopathic medicine, “We are all Toxic.” Between environmental toxins ... of potential greatness, and our high stress levels, we ...
(Date:3/2/2015)... A cocaine snorting Oscar statue ... typical nip slip or scathing scuffle. A new take ... the streets of Hollywood as Paper Jesus’ rendition of ... and substance abuse in Hollywood. The Oscar statue is ... political stance on the travails of drug addiction in ...
Breaking Medicine News(10 mins):Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Calvary Hospital Honors Peter Acerios, RN, with Daisy Award 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3
... The AIUM is pleased to announce that ... endorse the recent AIUM Training Guidelines for the ... for a several practitioners, including physicians, osteopathic physicians, ... marking significant promise for the future of this ...
... heart trouble, study finds , TUESDAY, March 16 (HealthDay ... kick the habit, leading to a reduced risk of ... The study included more than 1,500 people taking part ... Before and one year after the participants stopped smoking, ...
... 16 The following is a statement from Charles Lyons , President and CEO of the Elizabeth Glaser Pediatric AIDS Foundation: , ... , , ... ... ...
... long been identified as a risk factor for cardiovascular disease ... at the University of Rochester Medical Center found that being ... of dying suddenly from cardiac causes. Scientists found that ... patients had a 76 percent increase in risk of ...
... found , TUESDAY, March 16 (HealthDay News) -- A ... early-stage lung tumors stable in patients who had inoperable ... the therapy, called stereotactic body radiation therapy (SBRT), were ... preliminary findings from a study published in the March ...
... diet as natural antioxidants is a good way forward for ... products. This has been shown by researchers from the Miguel ... place. Researchers from the Miguel Hernndez University have identified ... due to the fact they contain high levels of phenolic ...
Cached Medicine News:Health News:Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound 2Health News:Blood Vessels Bounce Back Once Smokers Quit 2Health News:Elizabeth Glaser Pediatric AIDS Foundation President and CEO Charles Lyons Welcomes the Appointment of Anthony Lake as New Executive Director of UNICEF 2Health News:As girth grows, risk of sudden cardiac death shrinks 2Health News:As girth grows, risk of sudden cardiac death shrinks 3Health News:Radiation May Help Those With Inoperable Lung Tumors 2Health News:Radiation May Help Those With Inoperable Lung Tumors 3Health News:Cloves are the best natural antioxidant 2
(Date:3/2/2015)... Diversified Holdings (NYSE: CODI ) ("CODI," "we," ... market businesses, announced today its consolidated operating results for ... Fourth Quarter 2014 Highlights , Generated ... "Cash Flow") of $17.5 million for the fourth quarter ... 2014;  , Reported net income of $8.9 million ...
(Date:3/2/2015)... 2015  DURECT Corporation (Nasdaq: DRRX ... the successful completion of a Phase 1 clinical ... DUR-928 is an endogenous, small-molecule, new chemical entity ... diseases such as nonalcoholic fatty liver disease (NAFLD) ... injuries such as acute kidney injury (AKI).        ...
(Date:3/2/2015)... March 2, 2015 Click here for additional ... Inc. (NYSE: DPLO ), the nation,s largest independent ... ended December 31, 2014. All comparisons, unless otherwise noted, are ... Fourth Quarter 2014 Highlights include: , ... Total prescriptions dispensed of 208,000, an increase of 11% ...
Breaking Medicine Technology:Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18
... U.S. approval in 1992, ABIOMED's BVS 5000 has ... cardiac assist system in the world to support ... by the U.S. Food and Drug Administration for ... ABIOMED continues to make advances with the BVS ...
... Left Ventricular Assist System (LVAS), manufactured by ... used as a destination therapy for patients ... heart failure, for which heart transplantation is ... is not intended as a bridge to ...
... System includes three major components: Blood pump, ... Portable Driver. This system provides partial or ... with conventional therapy, is unable to maintain ... accomplish support, blood flows from the natural ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
Medicine Products: